艾瑞製藥ARRY
那斯達克 · USD
4.60
+0.06
(+1.32%)
收盤 09/05 03:59 (UTC+8)
盤後
4.59
4.59
(-0.22%)
09/05 03:59 (UTC+8)
艾瑞製藥ARRY
4.60
+0.06
(+1.32%)
財務數據
損益表
- 1.53
- 2.56
- 2.31
- 2.75
- 3.02
- 3.62
- 3.93
- 2.26
- 2.23
- 3.42
- -55.09
- 66.73
- -9.52
- 18.94
- 9.86
- 19.80
- 8.63
- -42.55
- -1.16
- 53.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 342,065 | 223,412 | 226,044 | 393,491 | 362,243 | 302,363 | 275,232 | 231,406 | 255,766 | 153,403 |
營業成本 | 242,461 | 160,408 | 206,714 | 287,820 | 265,119 | 225,935 | 196,913 | 153,091 | 169,813 | 98,313 |
營業毛利 | 99,604 | 63,004 | 19,330 | 105,671 | 97,124 | 76,428 | 78,319 | 78,315 | 85,953 | 55,090 |
營業費用 | 64,839 | 55,895 | 167,436 | 60,220 | 50,748 | 49,144 | 220,665 | 210,990 | 46,351 | 46,676 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 56,766 | 47,818 | 56,628 | 53,262 | 45,104 | 43,795 | 46,059 | 40,110 | 37,474 | 37,049 |
非經常性項目費用 | - | - | 102,560 | - | - | - | 165,904 | 162,000 | - | - |
其他營業費用 | 8,073 | 8,077 | 8,248 | 6,958 | 5,644 | 5,349 | 8,702 | 8,880 | 8,877 | 9,627 |
營業利益 | 37,206 | 4,523 | -148,106 | 45,451 | 46,376 | 27,284 | -142,346 | -132,675 | 39,602 | 8,414 |
其他收入及費用 | 2,744 | 2,579 | 768 | 3,039 | 19,271 | 4,031 | 1,304 | 3,435 | 2,520 | 3,995 |
利息費用 | 5,786 | 5,563 | 5,482 | 5,046 | 8,768 | 8,035 | 9,007 | 8,264 | 8,614 | 8,940 |
稅前純益 | 31,723 | 4,125 | -152,820 | 43,444 | 56,879 | 23,280 | -150,049 | -137,504 | 33,508 | 3,469 |
所得稅 | 7,377 | 2,128 | -7,074 | 9,941 | 13,617 | 6,534 | -23,146 | 3,850 | 7,810 | 1,304 |
稅後純益 | 24,346 | 1,997 | -145,746 | 33,503 | 43,262 | 16,746 | -126,903 | -141,354 | 25,698 | 2,165 |
基本每股稅後盈餘(元) | 0.05 | -0.09 | -1.06 | 0.12 | 0.19 | 0.02 | -0.93 | -1.02 | 0.08 | -0.07 |
稀釋每股稅後盈餘(元) | 0.06 | -0.09 | -1.05 | 0.12 | 0.18 | 0.02 | -0.93 | -1.02 | 0.07 | -0.07 |
基本平均股數(千股) | 153866.00 | 152956.00 | 152752.00 | 152727.00 | 152584.00 | 152076.00 | 151944.00 | 151923.00 | 151797.00 | 151351.00 |
稀釋平均股數(千股) | 155685.00 | 152956.00 | 152752.00 | 154090.00 | 153068.00 | 152783.00 | 151944.00 | 151923.00 | 152207.00 | 151351.00 |
還原基本每股稅後盈餘(元) | 0.05 | -0.09 | -1.06 | 0.12 | 0.19 | 0.02 | -0.93 | -1.02 | 0.08 | -0.07 |
還原稀釋每股稅後盈餘(元) | 0.06 | -0.09 | -1.05 | 0.12 | 0.18 | 0.02 | -0.93 | -1.02 | 0.07 | -0.07 |
還原基本平均股數(千股) | 153,866 | 152,956 | 152,752 | 152,727 | 152,584 | 152,076 | 151,944 | 151,923 | 151,797 | 151,351 |
還原稀釋平均股數(千股) | 155,685 | 152,956 | 152,752 | 154,090 | 153,068 | 152,783 | 151,944 | 151,923 | 152,207 | 151,351 |
EBITDA(千元) | 54,116 | 25,929 | -130,877 | 61,609 | 77,494 | 42,392 | -126,761 | -114,491 | 56,641 | 27,726 |